4 Amendments of Aurore LALUCQ related to 2020/2071(INI)
Amendment 19 #
Draft opinion
Paragraph 2
Paragraph 2
2. RecognisDeplores that the EU depends on a narrow set of countries for a large proportion of its imports of active pharmaceutical ingredients and chemical raw materials; stresses that this over- reliance can poses a risk in times of crises, when limitations in production capacity, excess demand or protectionist measures threaten the proper functioning of global supply chains and potentially undermine the availability of medicines in the EU; calls on the Commission to present a long- term strategy focused on ensuring the EU’s open strategic autonomy in health, strengthening the European production of essential medicines;
Amendment 27 #
3. Emphasises that the EU is a leading global exporter of pharmaceutical products; notes that the protection and enforcement of IP rights in free trade agreements (FTAs) and at the WTO is crucial to the development of new medicines and treatments; underlines that the flexibilities provided in the TRIPS agreement can be used to address potential supply shortages in exceptional circumstanchowever that the TRIPS agreement should be reviewed to ensure that it meets developing countries’ access to essential medicines;
Amendment 39 #
Draft opinion
Paragraph 4
Paragraph 4
4. Emphasises that a broad network of FTAs together withWelcomes the Commissioner for Internal Market’s statements on the reshoring of strategic supply chains; notes that a functioning multilateral trading system constitute the best way of guaranteeing that multiple sources of manufacturing for essential medicines are available and regulatory standards converge globallycould serve as a complement to the European production;
Amendment 59 #
Draft opinion
Paragraph 6
Paragraph 6
6. Underlines that a complete repatriation of all medical supply chains is not possible in a global economy; urges the Commission and the Member States to work with the EU’s partners, the WHO and WTO, on establishing an international framework that can prevent the breakdown of supply chains and limit resort to protectionist measures during health crises.